drugset / Trial / NCT00154895

Additional Minocycline Pleurodesis After Thoracoscopic Procedures for Primary Spontaneous Pneumothorax

NCT00154895

RandomizedParallel-groupOpen-labelTreatment

Summary

To test if additional minocycline pleurodesis after thoracoscopic procedures can reduce the rates of ipsilateral recurrence for patients with primary spontaneous pneumothorax.

Timeline

Start
2001-06
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 300 mg Other
Subject Minocycline Small molecule 400 mg Other

Indications